We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-16.6%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$3.41M
Cap. Flow
+$220M
Cap. Flow %
21.29%
Top 10 Hldgs %
43.95%
Holding
852
New
247
Increased
177
Reduced
137
Closed
202

Sector Composition

Rank Sector Weight
1 Healthcare 28.69%
2 Financials 13.57%
3 Materials 7.25%
4 Technology 4.61%
5 Industrials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASLE icon
51
AerSale
ASLE
$279M
$2.6M 0.25%
178,803
FOXO
52
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$2.5M 0.24%
+1,256
New +$2.5M
BKEP
53
DELISTED
Blueknight Energy Partners L.P.
BKEP
$2.49M 0.24%
+550,000
New +$2.34M
MRNA icon
54
Moderna
MRNA
$23.6B
$2.43M 0.23%
17,002
TGT icon
55
PUT
Target
TGT
$68B
$2.37M 0.23%
24,900
+3,900
+19% +$748K
PACX
56
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$2.22M 0.21%
225,000
+25,000
+13% +$246K
OYST
57
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$2.21M 0.21%
509,794
ISAA
58
DELISTED
Iron Spark I Inc. Class A Common Stock
ISAA
$2.16M 0.21%
218,650
+193,066
+755% +$1.92M
BREZ
59
DELISTED
Breeze Holdings Acquisition Corp. Common Stock
BREZ
$2.05M 0.2%
+200,000
New +$2.06M
HGEN
60
DELISTED
HUMANIGEN, INC.
HGEN
$2M 0.19%
1,128,174
+378,174
+50% +$849K
NOAC
61
DELISTED
Natural Order Acquisition Corp. Common Stock
NOAC
$1.98M 0.19%
200,000
-200
-0.1% -$1.97K
TWTR
62
DELISTED
Twitter, Inc.
TWTR
$1.87M 0.18%
+50,109
New +$2.15M
TSIB
63
DELISTED
Tishman Speyer Innovation Corp. II Class A common stock
TSIB
$1.86M 0.18%
190,000
-10,000
-5% -$98K
REVHU
64
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
$1.84M 0.18%
+187,900
New +$1.85M
CND
65
DELISTED
Concord Acquisition Corp.
CND
$1.82M 0.18%
186,498
CHPT icon
66
ChargePoint
CHPT
$161M
$1.7M 0.16%
+6,195
New +$1.72M
ADOC
67
DELISTED
Edoc Acquisition Corp. Class A Ordinary Share
ADOC
$1.63M 0.16%
+160,000
New +$1.63M
FHN icon
68
First Horizon
FHN
$12.1B
$1.57M 0.15%
72,014
+4,498
+7% +$101K
NVDA icon
69
NVIDIA
NVDA
$5.42T
$1.52M 0.15%
+100,000
New +$1.89M
BIOT
70
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$1.49M 0.14%
+150,000
New +$1.47M
CFIV
71
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
$1.44M 0.14%
146,654
-65,260
-31% -$642K
DSAC
72
DELISTED
Duddell Street Acquisition Corp. Class A Ordinary Shares
DSAC
$1.38M 0.13%
+139,006
New +$1.38M
NRGV icon
73
Energy Vault
NRGV
$633M
$1.34M 0.13%
+133,825
New +$1.74M
WFC icon
74
Wells Fargo
WFC
$264B
$1.29M 0.12%
32,990
-3,793
-10% -$166K
XLE icon
75
State Street Energy Select Sector SPDR ETF
XLE
$37.6B
$1.28M 0.12%
+35,802
New +$1.44M

Similar funds

Cowen and Company's Q2 2022 Portfolio in Review

As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.

  • Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
  • Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
  • Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
  • Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
  • Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
  • Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
  • Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.